ClearPoint Neuro Inc. (CLPT) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
120 S. SIERRA AVENUE SOLANA BEACH, CA 92075 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 23,140 | 24,342 | 26,464 | 31,735 | 37,489 | 40,461 | |||
| Cash and cash equivalents | 23,140 | 24,342 | 26,464 | 21,792 | 27,615 | 18,712 | |||
| Short-term investments | 9,943 | 9,874 | 21,749 | ||||||
| Receivables | 3,211 | 2,424 | 2,799 | 2,678 | 2,665 | 3,411 | |||
| Inventory, net of allowances, customer advances and progress billings | 7,911 | 8,987 | 9,204 | 9,808 | 9,303 | 8,284 | |||
| Inventory | 7,911 | 8,987 | 9,204 | 9,808 | 9,303 | 8,284 | |||
| Contract with customer, asset, after allowance for credit loss | 600 | ||||||||
| Other undisclosed current assets | 1,910 | 957 | 2,244 | 1,764 | 1,723 | 1,658 | |||
| Total current assets: | 36,172 | 37,310 | 40,711 | 45,985 | 51,180 | 53,814 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 386 | 405 | 407 | 450 | 450 | 485 | |||
| Operating lease, right-of-use asset | 3,564 | 3,689 | 3,956 | 1,762 | 1,895 | 1,866 | |||
| Property, plant and equipment | 1,389 | 1,355 | 1,360 | 949 | 806 | 629 | |||
| Intangible assets, net (including goodwill) | 1,041 | 969 | 1,051 | 970 | 1,028 | 850 | |||
| Intangible assets, net (excluding goodwill) | 1,041 | 969 | 1,051 | 970 | 1,028 | 850 | |||
| Other noncurrent assets | 109 | 109 | 156 | 131 | 131 | 94 | |||
| Total noncurrent assets: | 6,489 | 6,527 | 6,930 | 4,262 | 4,310 | 3,924 | |||
| TOTAL ASSETS: | 42,661 | 43,837 | 47,641 | 50,247 | 55,490 | 57,738 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4,393 | 4,030 | 4,985 | 4,202 | 5,161 | 4,823 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 2,187 | ||
| Accounts payable | 393 | 789 | 1,273 | 1,352 | 272 | 1,387 | |||
| Accrued liabilities | 4,000 | 3,241 | 3,712 | 2,850 | 4,889 | 1,249 | |||
| Deferred revenue | 2,613 | 1,175 | 724 | 1,281 | 1,066 | 735 | |||
| Debt | |||||||||
| Customer refund liability | 500 | ||||||||
| Other undisclosed current liabilities | 424 | 384 | 493 | 571 | 61 | 537 | |||
| Total current liabilities: | 7,430 | 5,589 | 6,202 | 6,054 | 6,788 | 6,095 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 9,949 | 9,935 | 9,921 | 9,907 | 9,893 | 11,414 | |||
| Long-term debt, excluding current maturities | 9,949 | 9,935 | 9,921 | 9,907 | 9,893 | 9,879 | |||
| Liabilities, other than long-term debt | 4,109 | 4,219 | 4,108 | 1,706 | 1,922 | 351 | |||
| Deferred revenue | 541 | 524 | 253 | 320 | 390 | 351 | |||
| Operating lease, liability | 3,568 | 3,695 | 3,855 | 1,386 | 1,532 | 1,535 | |||
| Total noncurrent liabilities: | 14,058 | 14,154 | 14,029 | 11,613 | 11,815 | 11,765 | |||
| Total liabilities: | 21,488 | 19,743 | 20,231 | 17,667 | 18,603 | 17,860 | |||
| Equity | |||||||||
| Equity, attributable to parent | 21,173 | 24,094 | 27,410 | 32,580 | 36,887 | 39,878 | |||
| Common stock | 247 | 246 | 246 | 246 | 246 | 245 | |||
| Additional paid in capital | 193,382 | 191,685 | 190,192 | 188,310 | 187,008 | 185,615 | |||
| Accumulated deficit | (172,456) | (167,837) | (163,028) | (155,976) | (150,367) | (145,982) | |||
| Total equity: | 21,173 | 24,094 | 27,410 | 32,580 | 36,887 | 39,878 | |||
| TOTAL LIABILITIES AND EQUITY: | 42,661 | 43,837 | 47,641 | 50,247 | 55,490 | 57,738 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,810 | 5,762 | 5,950 | 5,433 | 5,174 | 5,146 | ||
| Cost of revenue | (2,797) | (2,489) | (2,824) | (2,231) | (1,858) | (1,434) | ||
| Gross profit: | 4,013 | 3,273 | 3,126 | 3,202 | 3,316 | 3,712 | ||
| Operating expenses | (5,372) | (5,329) | (6,783) | (5,981) | (4,598) | (5,368) | ||
| Other undisclosed operating loss | (3,347) | (2,841) | (3,474) | (2,933) | (3,187) | (2,139) | ||
| Operating loss: | (4,706) | (4,897) | (7,131) | (5,712) | (4,469) | (3,795) | ||
| Nonoperating expense (Other Nonoperating expense) | (4) | (12) | (2) | (11) | (25) | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (81) | |||||||
| Loss from continuing operations: | (4,710) | (4,909) | (7,133) | (5,723) | (4,550) | (3,820) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | (3,820) | |
| Net loss: | (4,710) | (4,909) | (7,133) | (5,723) | (4,550) | (3,820) | ||
| Other undisclosed net income attributable to parent | 91 | 100 | 81 | 114 | 165 | 32 | ||
| Net loss available to common stockholders, diluted: | (4,619) | (4,809) | (7,052) | (5,609) | (4,385) | (3,788) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (4,710) | (4,909) | (7,133) | (5,723) | (4,550) | (3,820) | ||
| Comprehensive loss, net of tax, attributable to parent: | (4,710) | (4,909) | (7,133) | (5,723) | (4,550) | (3,820) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.